[The evolution of lumbar myalgia under the influence of the product Pelnicol administered in suppositories].
After having done a wide study in vitro and in vivo reported in several publications, we applied the lyophylized extract "Pelnicol" under the form of suppositories, in 36 cases of secondary back diseases. The improvement with "Pelnicol" suppositories is observed, by mean, the 6th day of treatment. It can be seen that etiopathological factors are determining the diseases evolution, which has to be, in first rang, considered causally. It is realised with the "Pelnicol" suppositories.
Verbuţă
A
A
Facultatea de Farmacie, Catedra de Chimie Farmaceutică, Universitatea de Medicina şi Farmacie Gr.T. Popa Iaşi.
Bejan
V
V
D000328:Adult; D005260:Female; D006801:Humans; D008055:Lipids; D017116:Low Back Pain / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009094:Mud Therapy / Q000009:adverse effects / Q000379:methods*; D013488:Suppositories / Q000008:administration & dosage* / Q000009:adverse effects; D013997:Time Factors; D016896:Treatment Outcome
D008055:Lipids; D013488:Suppositories; C407908:pelnicol